Bank Hapoalim Bm Biond Vax Pharmaceuticals Ltd. Transaction History

Bank Hapoalim Bm

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$2.5 - $40.97 $16,275 - $266,714	-6,510 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$23.7 - $51.1 $61,217 - $131,991	-2,583 Reduced 28.41%	6,510 $254,000
Q2 2020 Aug 04, 2020	BUY	$7.2 - $24.87 $65,469 - $226,142	9,093 New	9,093 $207,000
Q1 2020 May 06, 2020	SELL	$5.36 - $11.65 $133,603 - $290,387	-24,926 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$3.97 - $5.99 $992 - $1,497	-250 Reduced 0.99%	24,926 $119,000
Q3 2018 Nov 08, 2018	SELL	$5.5 - $6.78 $9,625 - $11,865	-1,750 Reduced 6.5%	25,176 $141,000
Q1 2018 Apr 30, 2018	BUY	$5.43 - $7.49 $146,208 - $201,675	26,926 New	26,926 $146,000

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

Stay updated on Bank Hapoalim Bm with notifications on news.